Â鶹´«Ã½

‘We noticed that the patient monitoring processes in hospitals are inefficient. They also lack digital solutions and generate unnecessary manual and administrative tasks for the overworked nurses and doctors.’ says Miklós Knébel.

Knebel and Péter Dános participated in a project run by EIT Digital Master School in which students designed a new type of medical device for monitoring patient vital signs. The device consists of a 3D-printed wristband that can remotely monitor patients’ vital signs, such as body temperature, oxygen saturation, pulse, and respiratory rate.

This device utilises IoT technology to quickly and securely send the patients’ data to a medical software platform. This allows multiple patients to be followed simultaneously, increasing time efficiency for medical staff.

The device reports problems in real-time

One benefit of the remote monitoring device over traditional manual monitoring of patient vitals is that medical staff can immediately notice changes in a patient’s condition and act accordingly.

‘As an example, the increase in a patient’s temperature is usually the first indicator of an infection, but respiratory- and other acute issues can also be immediately noticed with Entremo’s system. Time is often of the essence in health care – so the quicker a change in a patient’s condition is noticed, the fewer complications that will occur,’ says Knébel.

It is especially beneficial for monitoring patients with Covid-19 as it does not require close contact between medical staff and the patient. The device is also helpful in the care of patients with other respiratory diseases.

Funding boosts innovation

A team of six international students developed the device. This founding team won the EUvsVirus award in April 2020, the goal of which was to develop innovative digital solutions for coronavirus-related challenges.

In September 2020, they received a EUR 500 000 investment from EIT Digital and its partners to develop their medical device. EIT Digital is part of EIT, which stands for the European Institute of Innovation and Technology. Thanks to this innovation funding, the startup company Entremo was established.

The Entremo team is using the EIT Digital investment to develop their minimal viable product. According to Knébel, there is still a critical phase left: testing and validation with patients on a broader scale.

This spring, the device is being tested in nursing homes and hospitals in Hungary.

‘We have high hopes, but we still need external feedback on what should be changed or improved. We developed this solution based on consultations with health care workers and other professionals to be a useful tool in a hospital setting. However, we will only know if we have succeeded when it is validated in practice.’ says Dános.

This article will be published in the Aalto University Magazine issue 28, May 2021.

Text: Saana Kallioinen

Photos: Entremo